analogue

(redirected from Insulin analog)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

analogue

(sometimes US), analog
1. 
a. a physical object or quantity, such as a pointer on a dial or a voltage, used to measure or represent another quantity
b. (as modifier): analogue watch
2. Biology an analogous part or organ
3. Chem
a. an organic chemical compound related to another by substitution of hydrogen atoms with alkyl groups
b. an organic compound that is similar in structure to another organic compound

analogue

(electronics)
(US: "analog") A description of a continuously variable signal or a circuit or device designed to handle such signals. The opposite is "discrete" or "digital".

Analogue circuits are much harder to design and analyse than digital ones because the designer must take into account effects such as the gain, linearity and power handling of components, the resistance, capacitance and inductance of PCB tracks, wires and connectors, interference between signals, power supply stability and more. A digital circuit design, especially for high switching speeds, must also take these factors into account if it is to work reliably, but they are usually less critical because most digital components will function correctly within a range of parameters whereas such variations will corrupt the outputs of an analogue circuit.

See also analogue computer.

analogue

The British and European spelling of analog.
References in periodicals archive ?
Indication: HUMALOG is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
Other products like insulin analogs, EPO, enzymes, and growth hormones are expected to grow at a medium pace.
A third insulin analog on the market, insulin glulisine (Apidra), approved in 2004, has a pharmacokinetic profile that is similar to insulin aspart and lispro, but Mr.
The study shows, however, that the IGF-1 receptor is not involved in the mode of action of AspB10, the only insulin analog shown to have a carcinogenic effect.
Intrapatient insulin absorption can be highly variable and this study evaluates and quantifies the ability of PH20 to produce a more consistent PK profile relative to the PK variability produced by the insulin analog alone.
Mylan President Rajiv Malik added, "These noteworthy clinical trial developments, combined with the significant strides we have made in advancing our production scale manufacturing, reinforce our continued belief that Mylan will be the first to bring to market an AB-rated, substitutable generic form of Advair Diskus and one of the first to bring to market an interchangeable insulin analog to Lantus.
Mylan CEO Heather Bresch commented, "This collaboration builds off of our existing successful partnership for generic biologics with Biocon and brings Mylan a portfolio of high-value insulin analog products.
This is because most insulin assays do not show linear recovery with insulin analog and have different cross-reactivity with insulin analogs (6).
In addition to supporting regulatory submissions, these studies will be conducted to evaluate safety, efficacy and differentiation of this novel basal insulin analog.
Summary: Sanofi-aventis announced yesterday that the European Commission has approved APIDRAA (insulin glulisine [rDNA origin] injection), a rapid-acting insulin analog for the control of hyperglycemia in adolescents and children (6 years and older) with diabetes.
European Commission has approved Apidra, a rapid-acting insulin analog for the control of hyperglycemia in adolescents and children with diabetes, Sanofi-aventis has announced.